John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

New nutritional therapies in Crohn's disease. What can we learn from the paediatric experience? Volume 29, issue 2, February 2022

Tables

Authors
1 Hospices Civils de Lyon, Hôpital Femme Mère Enfant, service de gastroentérologie, hépatologie et nutrition pédiatrique, 59 boulevard Pinel, 69500 Bron
2 INSERM U1111, Centre International de Recherche en Infectiologie, 46 allée d’Italie, 69007 Lyon
3 Hospices Civils de Lyon, Hôpital Lyon Sud, service de gastroentérologie, 165 chemin du Grand Revoyet, 69310 Pierre-Bénite
* Correspondance

Environmental factors play a critical role as trigger of inflammation in inflammatory bowel disease (IBD) and nutritional factors contribute to pathology of IBD. Moreover, exclusive enteral nutrition (EEN) is now considered, as the first line induction therapy for mild to severe paediatric Crohn disease (CD) without anoperineal disease. Recently, new therapeutic nutrition protocols such as “Crohn disease exclusion diet” have been prospectively evaluated in paediatric CD patients. Some of them reported promissing results. Yet, these new therapeutic options, validated in paediatric, could also be proposed to adult patients. Overall, new nutritional approaches will require new financial resources for dietetician and therapeutic education founding.